SAFETY AND EFFICACY OF THYMOPENTIN IN ZIDOVUDINE (AZT)-TREATED ASYMPTOMATIC HIV-INFECTED SUBJECTS WITH 200-500 CD4 CELL MM(3) - A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL (VOL 8, PG 279, 1995)/

GOLDSTEIN G CONANT MA BEALL G GROSSMAN HA GALPIN JE BLICK G CALABRESE LH HIRSCH RL FISHER A STAMPONE P MEYERSON LA

G. Goldstein et al., SAFETY AND EFFICACY OF THYMOPENTIN IN ZIDOVUDINE (AZT)-TREATED ASYMPTOMATIC HIV-INFECTED SUBJECTS WITH 200-500 CD4 CELL MM(3) - A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL (VOL 8, PG 279, 1995)/, Journal of acquired immune deficiency syndromes and human retrovirology, 11(3), 1996, pp. 315-315

1

Immunology,"Infectious Diseases

Journal of acquired immune deficiency syndromes and human retrovirology → ACNP

10779450

11

3

1996

315 - 315

ISI

1077-9450(1996)11:3<315:SAEOTI>2.0.ZU;2-N